CLERICO, ALDO
 Distribuzione geografica
Continente #
AS - Asia 1.536
NA - Nord America 1.403
EU - Europa 1.086
SA - Sud America 299
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 4.374
Nazione #
US - Stati Uniti d'America 1.322
IT - Italia 773
SG - Singapore 624
CN - Cina 365
BR - Brasile 227
VN - Vietnam 145
HK - Hong Kong 143
NL - Olanda 106
FR - Francia 75
BD - Bangladesh 73
KR - Corea 56
CA - Canada 37
GB - Regno Unito 31
DE - Germania 27
IN - India 25
AR - Argentina 23
JP - Giappone 20
FI - Finlandia 17
EC - Ecuador 16
CO - Colombia 14
ID - Indonesia 13
MX - Messico 13
IL - Israele 9
TR - Turchia 9
ZA - Sudafrica 9
VE - Venezuela 8
ES - Italia 7
JM - Giamaica 7
MA - Marocco 7
IQ - Iraq 6
PK - Pakistan 6
PL - Polonia 6
CR - Costa Rica 5
KE - Kenya 5
MY - Malesia 5
PH - Filippine 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
SE - Svezia 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BB - Barbados 3
DZ - Algeria 3
IE - Irlanda 3
KZ - Kazakistan 3
LB - Libano 3
SM - San Marino 3
TW - Taiwan 3
AO - Angola 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
JO - Giordania 2
NP - Nepal 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
CV - Capo Verde 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PF - Polinesia Francese 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 4.367
Città #
Singapore 375
Santa Clara 358
Hong Kong 139
Hefei 126
Beijing 100
San Jose 98
Ashburn 90
Rome 79
Lauterbourg 60
Seoul 55
Milan 51
Hanoi 46
Los Angeles 44
Ho Chi Minh City 43
Dallas 42
Naples 29
New York 27
Florence 24
São Paulo 21
Buffalo 20
Atlanta 17
Bari 16
Bologna 16
Helsinki 16
Council Bluffs 15
Turin 15
Modena 14
Genoa 12
Palermo 12
Denver 11
Frankfurt am Main 11
Falkenstein 10
Belo Horizonte 9
Chicago 9
Houston 9
Orem 9
Minamishinagawa 8
Montreal 8
Padua 8
Phoenix 8
Rio de Janeiro 8
Brasília 7
Brooklyn 7
Curitiba 7
Da Nang 7
Messina 7
Bengaluru 6
Monza 6
Perugia 6
Salvador 6
Tokyo 6
Toronto 6
Washington 6
Buenos Aires 5
Chennai 5
Newark 5
Osaka 5
Quito 5
San Diego 5
San José 5
Solza 5
Warsaw 5
Ankara 4
Bollate 4
Detroit 4
Elk Grove Village 4
Guangzhou 4
Guayaquil 4
Kingston 4
London 4
Macerata 4
Martinengo 4
Milwaukee 4
Nairobi 4
New Delhi 4
Ninh Bình 4
Novate Milanese 4
Paris 4
Philadelphia 4
Sorocaba 4
Stockholm 4
Thái Bình 4
Trieste 4
Verona 4
Addis Ababa 3
Baghdad 3
Baku 3
Betim 3
Bogotá 3
Bolzano 3
Boston 3
Bridgetown 3
Bắc Giang 3
Cagliari 3
Cao Lanh 3
Capitol Heights 3
Cascina 3
Catania 3
Changsha 3
Delhi 3
Totale 2.326
Nome #
CONTROLLO DI QUALITÀ IN MEDICINA DI LABORATORIO: STATO DELL'ARTE E POSSIBILI INNOVAZIONI 1.029
Aerobic training decrease B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. 100
Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients. 85
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure 83
Atrial (ANP) and Brain (BNP) Natriuretic Peptides, Endothelin and ET binding sites in human heart failure 77
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 77
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretis peptide in humans 69
Endothelin-1, Endothelin-1receptors and cardiac natriuretic peptides in human failing heart 68
Cardiac natriuretic hormones: methodological aspects 68
Granulocyte- and monocyte-platelet adhesion index in coronary and peripheral blood after extracorporeal circulation and reperfusion 68
Stato dell'arte della misura degli ormoni tiroidei liberi come evidenziato dal Controllo di Qualità Esterno 64
Evaluation of the endocrine function of the heart in humans: proposal for an integrated approach for the assessment of production, secretion, distribution and degradation of atrial natriuretic factor and related peptides 63
Livelli plasmatici dei peptidi natriuretici cardiaci (ANP e BNP) nei pazienti uremici in emodialisi cronica. 59
Evaluation of reproducibility of the cTnT immunoassay using quality control samples 58
SERCA2a, Phospholamban, Sarcolipin, and Ryanodine Receptors Gene Expression in Children with Congenital Heart Defects 58
Determinazione dei peptidi natriuretici cardiaci (ANP,BNP,E PEPTIDI CORRELATI):caratteristiche analitiche ed utilità clinica 57
Low triiodothyronine and exercise capacity in heart failure 56
Evidence that atrial natriuretic peptide tissue extraction is not changed by large increases in its plasma levels induced by pacing in humans 56
Analytical performance and diagnostic accuracy of immunometricassays for the measurement of plasma BNP and NT-proBNP concentrations. 56
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia 54
Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. 54
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 54
Determination of endothelin binding sites in bovine atrial and ventricular membranes: a model for binding studies in human cardiac tissue 53
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay 52
Multicentre comparison of BNP andNT-proBNP immunoassays: the CardioOrmocheck study 52
Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone 50
Atrial Natriuretic peptide is not degraded by the lungs in humans 50
Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation 49
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice 49
C-type natriuretic peptide plasma levels and whole blood mrna expression show different trends in adolescents with different degree of endothelial dysfunction 48
Prognostic Value of Combined Measurement of Brain Natriuretic Peptide and Triiodothyronine in Heart Failure 47
Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. 46
Importanza dei metodi di dosaggio dei peptidi cardiaci natriuretici (ANP e BNP) nella valutazione clinica dei pazienti con scompenso cardiaco. 44
Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: The need for a new generation of immunoassay methods 44
Harmonization of free thyroid hormone tests: a mission impossible? 44
The humoral, renal and pressor effects of systemic L-arginine infusion in hypertensive patients. 44
Laboratory evaluation of inflammatory reaction following percutaneous transluminal coronary angioplasty (PTCA). 42
Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure 41
Cardiac natriuretic hormone system as a target for cardiovascular therapy 41
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training 39
Preparation of mono-radio-iodinated tracers for kinetic studies of cardiac natriuretic peptide in humans. 38
Thyroid Function and Cardiac Surgery: What Should We Measure, and When? 38
Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. 38
Osteopontin and interleukin-6 as markers of restenosis after coronary angioplasty? 38
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. 38
Plasmatic Levels Of Cardiac Natriuretic Hormones In Healthy Adults: Effects Of Age And Sex. 38
Evaluation of Analytical Performance of the Siemens ADVIA TnI Ultra Immunoassay. 38
Preparazione di endotelina radiomarcata per studi di legame su tessuto cardiaco. 36
Imaging and laboratory biomarkers in cardiovascular disease 36
Effects of different anti-aging dietary restrictions on endothelin-1 receptors in rat lung 34
Endothelin-1, endothelin-1 receptors and cardiac natriuretic peptides in failing human heart 33
Livelli plasmatici di adrenomedullina in pazienti con insufficienza renale prima e dopo emodialisi. 32
Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. 32
Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms. 32
Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure 32
Determinazione dei siti di legame dell'endotelina su membrane di atrio e di ventricolo bovino: un modello per studi di legame su tessuto cardiaco umano 31
Endothelin binding sites in human cardiac tissue from pediatric patients. 31
Influence of gender on circulating cardiac natriuretic hormones in patients heart failure 31
125-I-Endothelin-1 binding sites in human cardiac tissue 30
Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared. 30
Atrial (ANP) and Brain (BNP) Natriuretic Peptides, Endothelin and ET binding sites in human heart failure 30
Determination of endothelin binding sites in bovine atrium and ventricle membranes: a model for binding studies in human cardiac tissue. 29
Sviluppo di un metodo analitico per la separazione e la misura delle isoforme dell'endotelina in campioni biologici umani. 29
Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. 28
Analitical characteristics and clinical usefulness of an Irma for Brain Natriuretic Peptide (BNP) in plasma samples and cardiac tissue extracts. 28
Methodological implications and clinical usefulness of IRMA methods for the measurement of natriuretic cardiac peptides. 28
[Physiological significance and clinical utility of analytical methods for cardiac natriuretic peptides]. 27
Determination of N-terminal pro-ANP in plasma and cardiac tissue extracts: comparison of competitive and non-competitive immunoassays. 26
Plasma levels of atrial and brain natriuretic peptide in patients with renal insufficiency. 26
Atrial natriuretic peptide (ANP) binding sites on human platelets: an useful tool to evaluate the regulation of ANP receptors in humans 26
Immunoassay methods for the measurement of natriuretic cardiac Hormones - ANP, BNP, and related peptides - in humans 24
Methodological assessment of HPLC separation of endothelin (ET) isoforms in human biological samples 24
Plasma levels of Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and N-terminal fragment of Pro-ANP in Heart Failure and in controls. 22
Measurement of N-Terminal fragment of Proatrial Natriuretic peptide in Human Plasma by a new immunoradiometric assay: relationship with atrial and brain natriuretic peptides. 21
Endothelin and cardiac natriuretic peptides in heart failure. 19
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure 18
Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. 18
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides. 17
Totale 4.374
Categoria #
all - tutte 12.152
article - articoli 10.060
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 422
Totale 22.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202416 0 0 0 0 0 0 0 0 1 0 7 8
2024/20251.315 2 7 108 56 291 93 32 50 55 77 275 269
2025/20262.588 125 197 173 336 492 141 264 130 134 176 149 271
2026/2027455 142 86 227 0 0 0 0 0 0 0 0 0
Totale 4.374